Search

1. Medicare Part D's medication therapy management: shifting from neutral to drive

Publication:

Washington, D.C. : AARP Public Policy Institute, c2012

Subject(s):

Medicare Part D -- organization & administration
Medication Therapy Management -- organization & administration
Connecticut
United States
Centers for Medicare & Medicaid Services (U.S.)

2. The Medicare drug benefit (Part D): the basics

Publication:

Washington, DC : George Washington University, January 4, 2016

Subject(s):

Insurance Benefits
Insurance, Pharmaceutical Services
Medicare Part D -- organization & administration
United States

3. Medicare Part D

Author(s):

Steiner, David J., author

Publication:

[Toronto, Ontario] : Thomson Reuters, 20-December-2021

Subject(s):

Medicare Part D -- organization & administration
Medicare Part D -- legislation & jurisprudence
Prescription Drugs -- economics
United States

4. Part D plans generally include drugs commonly used by dual eligibles: 2020

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, June 2020

Subject(s):

Dual MEDICAID MEDICARE Eligibility
Government Regulation
Medicare Part D -- organization & administration
Pharmaceutical Preparations -- supply & distribution
United States
United States. Department of Health and Human Services

5. Opioid use in Medicare Part D continued to decline in 2019, but vigilance is needed as COVID-19 raises new concerns

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, August 2020

Subject(s):

COVID-19 -- economics
Fraud -- prevention & control
Government Regulation
Medicare Part D -- organization & administration
Opioid-Related Disorders -- economics
United States
United States. Department of Health and Human Services

6. Medicare Part D: CMS should monitor effects of rebates on plan formularies and beneficiary spending : report to congressional requesters

Publication:

Washington, DC : United States Government Accountability Office, September 2023

Subject(s):

Drug Costs
Government Regulation
Legislation, Medical
Medicare Part D -- economics
Medicare Part D -- organization & administration
Prescription Fees
United States
Centers for Medicare & Medicaid Services (U.S.)

7. Medicare Part D: CMS should monitor effects of rebates on drug coverage and spending : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives

Publication:

Washington, DC : United States Government Accountability Office, September 19, 2023

Subject(s):

Government Regulation
Legislation, Medical
Medicare Part D -- economics
Medicare Part D -- organization & administration
Prescription Drugs -- economics
United States

8. Medicare Part D

Author(s):

Steiner, David J., author

Publication:

[Toronto, Ontario] : Thomson Reuters, 21-December-2020

Subject(s):

Medicare Part D -- organization & administration
United States

9. Paying for drugs in Medicare Part D under current law and under proposals to redesign the program

Author(s):

Baker, Colin, author
Laughery, Scott, author

Publication:

[Washington, DC] : Congressional Budget Office, November 2021

Subject(s):

Cost Control
Drug Costs
Medicare Part D -- organization & administration
United States